FDA
approval
· 2018-07-20
FDA Approved: GEMCITABINE — Original Application (Sagent Pharmaceuticals)
Summary
FDA approves Sagent Pharmaceuticals' original ANDA for gemcitabine, a generic injectable chemotherapy used to treat several cancers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for GEMCITABINE (GEMCITABINE)